NO20051561L - Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. - Google Patents

Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine.

Info

Publication number: NO20051561L
Authority: NO; Norway
Prior art keywords: nucleic acid; acid molecules; human papillomavirus; molecules encoding; vaccine
Prior art date: 2002-10-03

Application number

NO20051561A

Other languages

English (en)

Norwegian (no)

Other versions

NO20051561D0 (no

Inventor

Gerald Wayne Gough

Christopher Michael Roberts

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-03

Filing date

2005-03-23

Publication date

2005-06-02

2005-03-23 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2005-03-23 Publication of NO20051561D0 publication Critical patent/NO20051561D0/no

2005-06-02 Publication of NO20051561L publication Critical patent/NO20051561L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20051561A 2002-10-03 2005-03-23 Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. NO20051561L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0222953.2A GB0222953D0 (en)	2002-10-03	2002-10-03	Novel Compounds
PCT/EP2003/011158 WO2004031222A2 (en)	2002-10-03	2003-10-01	Dna vaccine encoding at least two nonstructural early proteins of papillomavirus

Publications (2)

Publication Number	Publication Date
NO20051561D0 NO20051561D0 (no)	2005-03-23
NO20051561L true NO20051561L (no)	2005-06-02

Family

ID=9945247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20051561A NO20051561L (no)	2002-10-03	2005-03-23	Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine.

Country Status (21)

Country	Link
US (2)	US20060165713A1 (es)
EP (1)	EP1546191A2 (es)
JP (1)	JP2006516386A (es)
KR (1)	KR20050050115A (es)
CN (1)	CN100393878C (es)
AR (1)	AR041515A1 (es)
AU (1)	AU2003294672A1 (es)
BR (1)	BR0314986A (es)
CA (1)	CA2500093A1 (es)
CO (1)	CO5580837A2 (es)
GB (1)	GB0222953D0 (es)
IS (1)	IS7775A (es)
MA (1)	MA27474A1 (es)
MX (1)	MXPA05003558A (es)
NO (1)	NO20051561L (es)
NZ (1)	NZ539154A (es)
PL (1)	PL376534A1 (es)
RU (1)	RU2354701C2 (es)
TW (1)	TW200411055A (es)
WO (1)	WO2004031222A2 (es)
ZA (1)	ZA200503201B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA05004588A (es)	2002-10-29	2005-12-14	Coley Pharmaceutical Group Ltd	Metodos y productos relacionados con el tratamiento y prevencion de infeccion de virus de hepatitis c.
EP2118292B1 (en)	2007-01-30	2011-08-03	Transgene SA	Papillomavirus e2 polypeptide used for vaccination
GB0710538D0 (en) *	2007-06-01	2007-07-11	Glaxo Group Ltd	Vaccine
CN102985109B (zh) *	2010-06-25	2016-05-11	瓦西博迪公司	同型二聚体蛋白质构建体
IL251825B2 (en) *	2014-10-24	2023-09-01	Hpvvax Llc	Treatment of cancer and skin damage
JP2019505512A (ja)	2016-01-08	2019-02-28	バッシボディアクスイェセルスカプ	治療用抗癌ネオエピトープワクチン
EP3452081A1 (en) *	2016-05-04	2019-03-13	Transgene SA	Combination therapy with cpg tlr9 ligand

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPN443995A0 (en) *	1995-07-27	1995-08-17	Csl Limited	Papillomavirus polyprotein
GB0017990D0 (en) *	2000-07-21	2000-09-13	Glaxo Group Ltd	Papilloma virus sequences
IL154009A0 (en) *	2000-07-21	2003-07-31	Glaxo Group Ltd	Codon-optimized papilloma virus sequences

2002
- 2002-10-03 GB GBGB0222953.2A patent/GB0222953D0/en not_active Ceased
2003
- 2003-10-01 MX MXPA05003558A patent/MXPA05003558A/es not_active Application Discontinuation
- 2003-10-01 KR KR1020057005806A patent/KR20050050115A/ko active IP Right Grant
- 2003-10-01 AU AU2003294672A patent/AU2003294672A1/en not_active Abandoned
- 2003-10-01 BR BR0314986-2A patent/BR0314986A/pt not_active IP Right Cessation
- 2003-10-01 CN CNB2003801049852A patent/CN100393878C/zh not_active Expired - Fee Related
- 2003-10-01 WO PCT/EP2003/011158 patent/WO2004031222A2/en active Application Filing
- 2003-10-01 TW TW092127210A patent/TW200411055A/zh unknown
- 2003-10-01 PL PL376534A patent/PL376534A1/pl not_active Application Discontinuation
- 2003-10-01 NZ NZ539154A patent/NZ539154A/en unknown
- 2003-10-01 US US10/529,931 patent/US20060165713A1/en not_active Abandoned
- 2003-10-01 RU RU2005109155/13A patent/RU2354701C2/ru not_active IP Right Cessation
- 2003-10-01 EP EP03785608A patent/EP1546191A2/en not_active Withdrawn
- 2003-10-01 JP JP2004540797A patent/JP2006516386A/ja active Pending
- 2003-10-01 CA CA002500093A patent/CA2500093A1/en not_active Abandoned
- 2003-10-03 AR ARP030103608A patent/AR041515A1/es unknown
2005
- 2005-03-23 NO NO20051561A patent/NO20051561L/no not_active Application Discontinuation
- 2005-03-29 IS IS7775A patent/IS7775A/is unknown
- 2005-04-15 MA MA28223A patent/MA27474A1/fr unknown
- 2005-04-20 ZA ZA200503201A patent/ZA200503201B/en unknown
- 2005-04-28 CO CO05040562A patent/CO5580837A2/es not_active Application Discontinuation
2007
- 2007-06-08 US US11/760,127 patent/US20070264283A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2354701C2 (ru)	2009-05-10
US20060165713A1 (en)	2006-07-27
BR0314986A (pt)	2005-08-09
KR20050050115A (ko)	2005-05-27
CN1720261A (zh)	2006-01-11
CN100393878C (zh)	2008-06-11
PL376534A1 (pl)	2006-01-09
US20070264283A1 (en)	2007-11-15
AR041515A1 (es)	2005-05-18
CO5580837A2 (es)	2005-11-30
CA2500093A1 (en)	2004-04-15
EP1546191A2 (en)	2005-06-29
NZ539154A (en)	2007-05-31
MXPA05003558A (es)	2005-06-03
WO2004031222A2 (en)	2004-04-15
AU2003294672A1 (en)	2004-04-23
RU2005109155A (ru)	2006-03-10
MA27474A1 (fr)	2005-08-01
JP2006516386A (ja)	2006-07-06
NO20051561D0 (no)	2005-03-23
GB0222953D0 (en)	2002-11-13
IS7775A (is)	2005-03-29
TW200411055A (en)	2004-07-01
ZA200503201B (en)	2006-06-28
WO2004031222A3 (en)	2004-08-19

Publication	Publication Date	Title
BR112021024786A2 (pt)	2022-02-22	Construção de rna, sequência de ácido nucleico, cassete de expressão, vetor recombinante, composição farmacêutica, método para preparar a construção de rna, vacina, método para modificar uma célula ex vivo ou in vitro e célula modificada
BRPI0510428A (pt)	2007-10-30	composições tópicas de metadona e processos para utilização das mesmas
TW200507874A (en)	2005-03-01	Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
MY140840A (en)	2010-01-29	Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
EP1362127A4 (en)	2004-09-22	SERPIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV INFECTION AND THE USE THEREOF
NZ543467A (en)	2008-07-31	The severe acute respiratory syndrome coronavirus
NO20073059L (no)	2007-07-19	2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NO20060978L (no)	2006-05-26	Farmasoytiske blandingr for behandling av prematur ejakulasjon ved pulmonal inhalering
NO20064347L (no)	2006-09-26	Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20064059L (no)	2006-11-02	Albumin fusjonsproteiner
PL1962815T3 (pl)	2011-02-28	Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
HUP0401534A2 (hu)	2004-11-29	Módosított humán IX. faktor
NO20052071L (no)	2005-05-23	Bezofuranforbindelser, preparater og metoder for behandling og forebygging av hepatitt C virale infeksjoner og relaterte sykdommer.
MX2009008118A (es)	2009-10-13	Polipeptido e2 del virus del papiloma usado para vacunacion.
NO20075815L (no)	2008-01-11	Formuleringer og metoder for behandling av amyloidose
NO20083905L (no)	2008-09-12	Nye pyron-indol derivater og fremgangsmate for deres fremstilling
MX2009004243A (es)	2009-05-14	Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
ATE470443T1 (de)	2010-06-15	Indol-1-yl-essigsäurederivate
NO20052136L (no)	2005-07-11	Vaksine mot Hepatitt C-virus (HCV).
MX2022002766A (es)	2022-04-06	Vacunas contra el virus de la gripe y usos de las mismas.
NO20051561L (no)	2005-06-02	Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine.
NO20055624L (no)	2005-11-29	Tropanderivater og deres anvendelse som Ace-inhibitorer
WO2002078631A3 (en)	2004-01-29	Improved conditionally replicating vectors for inhibiting viral infections
NO20090067L (no)	2009-03-17	Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer
WO2009037183A3 (de)	2009-06-11	Nukleinsäurehaltige kosmetische und/oder pharmazeutische zubereitung zur induktion antimikrobieller peptide in epithelialen deckgeweben

Legal Events

Date	Code	Title	Description
2011-05-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application